FDA guidelines for biosimilar biotech drugs are positive to Korean drug makers

Published: 2012-02-22 06:56:00
Updated: 2012-02-22 06:56:00
The US Food and Drug Administration (FDA) has come up with guidelines for the sale of lower-cost versions of biotechnology drugs, issued on Thursday.

“These draft documents are designed to help the Korean drug industry develop biosimilar versions of currently approved biological products, whic...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.